Flt3L in Treating Patients With Metastatic Colorectal Cancer

ABSTRACT: RATIONALE: Flt3L may stimulate a person’s immune system and help kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of flt3L given to patients before undergoing surgery to remove metastases from colorectal cancer.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms,Metastatic Cancer

PROVIDER: 2002961 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR